• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Covid-19: Beginning 2021, India to produce 100 million doses of Russia’s Sputnik V vaccine

|

New Delhi, Nov 27: Russian Direct Investment Fund (RDIF) and pharma firm Hetero have agreed to produce over 100 million doses per year in India of the Sputnik V vaccine against COVID-19, Russia's sovereign wealth fund said in a statement.

RDIF, Hetero agree to produce over 100 mn doses of Sputnik V vaccine in India

The parties intend to start the production of Sputnik V in the beginning of 2021, it added.

    Oxford Astra Zeneca's vaccine error | What happens to India trials? | Oneindia News

    Currently Phase III clinical trials are approved and are ongoing in Belarus, the UAE, Venezuela and other countries. Phase II-III trials are taking place in India, RDIF said.

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    X